HealthcareServices

Plantar Fasciitis Treatment Market 2026–2030: Emerging Trends and Forecast Opportunities

March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the plantar fasciitis treatment market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Plantar Fasciitis Treatment Market from 2026 to 2030?

The plantar fasciitis treatment market has experienced significant expansion in recent years. It is projected to grow from $2.07 billion in 2025 to $2.55 billion in 2026, at a compound annual growth rate (CAGR) of 23.1%. The increase observed in the historic period is attributable to the increasing prevalence of foot and heel pain disorders, a rising incidence of obesity-related foot conditions, growing participation in sports activities, improved availability of physical therapy services, and the expansion of orthopedic care facilities.

The plantar fasciitis treatment market is anticipated to experience substantial growth in the coming years. This market is projected to reach $5.69 billion by 2030, with a compound annual growth rate (CAGR) of 22.2%. The expansion during this forecast period can be attributed to the increasing adoption of advanced diagnostic imaging, a rising demand for personalized orthotic products, the broadening of outpatient orthopedic treatments, a growing focus on preventive musculoskeletal care, and the greater integration of physical therapy into treatment protocols. Prominent trends expected in the forecast period involve the increasing embrace of non-invasive treatment options, a rising utilization of shockwave and physical therapy modalities, an escalating demand for custom orthotic solutions, the expansion of multidisciplinary foot care approaches, and an enhanced focus on early diagnosis and conservative care.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9385&type=smp

What Drivers Are Affecting Demand In The Plantar Fasciitis Treatment Market?

The growing prevalence of diabetes is expected to boost the expansion of the plantar fasciitis treatment market. Diabetes is a chronic health condition marked by elevated blood sugar levels, resulting from the body’s insufficient insulin production or its ineffective use. The application of plantar fasciitis treatment for individuals with diabetes aims to relieve foot pain and discomfort associated with plantar fascia inflammation, promoting improved mobility and reducing the risk of complications. For instance, in 2023, a report from the Health Data Institute revealed that approximately 529 million people worldwide were living with diabetes. Projections indicate that if current trends continue, this figure could rise to 1.3 billion by 2050. Therefore, the increasing rates of diabetes are driving the plantar fasciitis treatment market.

Which Segments Are Gaining Traction In The Plantar Fasciitis Treatment Market?

The plantar fasciitis treatment market covered in this report is segmented –

1) By Type: Medication Therapy, Orthotics, Shockwave Therapy, Surgery, Other Types

2) By Diagnosis: Medical History, Physical Examination, X-Rays, Radiography, Other Diagnosis

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Medication Therapy: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Pain Relievers, Topical Treatments

2) By Orthotics: Custom Orthotic Inserts, Over-The-Counter Insoles, Night Splints, Heel Cups

3) By Shockwave Therapy: Radial Shockwave Therapy, Focused Shockwave Therapy

4) By Surgery: Plantar Fascia Release, Gastrocnemius Recession, Other Surgical Procedures

5) By Other Types: Physical Therapy, Massage Therapy, Stretching And Strengthening Exercises, Alternative Therapies

Which Market Trends Are Opening Growth Opportunities In The Plantar Fasciitis Treatment Market?

Prominent companies operating in the plantar fasciitis treatment market are prioritizing the development of technological innovations, including wearable long-duration ultrasound devices for at-home soft-tissue therapy, with the goal of enhancing healing, reducing discomfort, and minimizing the need for invasive procedures. Such a wearable long-duration ultrasound device delivers sustained low-intensity ultrasonic energy directly to soft tissue, thereby stimulating blood flow, oxygenation, and cellular repair, presenting a non-invasive alternative to traditional orthotics, pain medications, or corticosteroid injections. For instance, in June 2025, ZetrOZ Systems, a US-based medical device manufacturer, unveiled the sam 2.0, an advanced wearable ultrasound device designed for plantar fasciitis treatment. This product offers multi-hour, low-intensity ultrasound therapy that promotes collagen deposition, accelerates soft-tissue repair, reduces inflammation, and can be self-administered at home, providing patients with a convenient, drug-free, non-surgical treatment solution.

Who Are The Core Companies Influencing Trends In The Plantar Fasciitis Treatment Market?

Major companies operating in the plantar fasciitis treatment market are Bayer AG, Superfeet Worldwide LLC, Bauerfeind AG, Ottobock SE & Co. KGaA, Sanofi SA, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer Inc., Bristol-Myers Squibb Company, Scholl’s Wellness Co., Hanger Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Smith & Nephew plc, Arthrex Inc., DJO Global Co., Medline Industries Inc., Bird & Cronin Inc., Aetrex Worldwide Inc., Zimmer Biomet Holdings Inc., Stryker Corporation, Breg Inc., TheraBand LLC, Foot Levelers Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/plantar-fasciitis-treatment-global-market-report

Which Regions Are Projected To Dominate The Plantar Fasciitis Treatment Market In The Coming Years?

North America was the largest region in the plantar fasciitis treatment market in 2025. The regions covered in the plantar fasciitis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Plantar Fasciitis Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9385&type=smp

Browse Through More Reports Similar to the Global Plantar Fasciitis Treatment Market 2026, By The Business Research Company

Scar Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/scar-treatment-global-market-report

Kernicterus Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/kernicterus-treatment-global-market-report

Fabry Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/fabry-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795